Salt Lake City, UT, United States of America

Kuberan Balagurunathan

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Massachusetts Institute of Technology. Active years: 2010-2013.

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kuberan Balagurunathan: Innovator in Anti-Coagulant Synthesis

Introduction

Kuberan Balagurunathan is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of biochemistry, particularly in the synthesis of anti-coagulants. With a total of 2 patents, his work has the potential to impact medical treatments related to coagulation and thrombosis.

Latest Patents

His latest patents include the "Rapid two-step synthesis of anti-coagulants." This invention provides methods for the production of N-deacetylate N-sulfate derivatives of non-sulfated N-acetyl heparosan (HS) polysaccharides. The compounds obtained from this process, along with their compositions, are aimed at controlling coagulation and treating thrombosis. Another significant patent is "Methods for synthesis of sulfated saccharides," which outlines methods, processes, and reaction mixtures that produce sulfated heparosan polysaccharides. This invention also details the synthesis of N-deacetylate N-sulfate derivatives of non-sulfated N-acetyl heparosan (HS) polysaccharides.

Career Highlights

Kuberan Balagurunathan is affiliated with the Massachusetts Institute of Technology, where he continues to advance his research and innovations. His work is characterized by a commitment to developing new methods that can lead to improved medical treatments.

Collaborations

He has collaborated with Robert D Rosenberg, further enhancing the scope and impact of his research.

Conclusion

Kuberan Balagurunathan's contributions to the field of anti-coagulant synthesis demonstrate his innovative spirit and dedication to improving medical science. His patents reflect a significant advancement in the production of essential compounds for treating coagulation disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…